These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34927243)

  • 1. MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.
    Yuan Q; Zhang J; Liu Y; Chen H; Liu H; Wang J; Niu M; Hou L; Wu Z; Chen Z; Zhang J
    J Pathol; 2022 Apr; 256(4):414-426. PubMed ID: 34927243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
    Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
    Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
    Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment.
    Liu WT; Jing YY; Gao L; Li R; Yang X; Pan XR; Yang Y; Meng Y; Hou XJ; Zhao QD; Han ZP; Wei LX
    Cell Death Differ; 2020 Jan; 27(1):85-101. PubMed ID: 31065105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
    Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
    Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
    [No Abstract]   [Full Text] [Related]  

  • 6. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
    Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
    Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
    Baglieri J; Brenner DA; Kisseleva T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.
    Zhang J; Liu Y; Chen H; Yuan Q; Wang J; Niu M; Hou L; Gu J; Zhang J
    Cell Death Dis; 2022 Apr; 13(4):411. PubMed ID: 35484116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog controls hepatic stellate cell fate by regulating metabolism.
    Chen Y; Choi SS; Michelotti GA; Chan IS; Swiderska-Syn M; Karaca GF; Xie G; Moylan CA; Garibaldi F; Premont R; Suliman HB; Piantadosi CA; Diehl AM
    Gastroenterology; 2012 Nov; 143(5):1319-1329.e11. PubMed ID: 22885334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization.
    Yuan Q; Gu J; Zhang J; Liu S; Wang Q; Tian T; Chen Z; Zhang J
    Cell Rep; 2021 Feb; 34(5):108724. PubMed ID: 33535045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
    Zheng D; Jiang Y; Qu C; Yuan H; Hu K; He L; Chen P; Li J; Tu M; Lin L; Chen H; Lin Z; Lin W; Fan J; Cheng G; Hong J
    Am J Pathol; 2020 Nov; 190(11):2267-2281. PubMed ID: 32805235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
    Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
    Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression.
    Liu Z; Mo H; Liu R; Niu Y; Chen T; Xu Q; Tu K; Yang N
    Cell Death Dis; 2021 Dec; 12(12):1134. PubMed ID: 34873170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness.
    Li Y; Wang J; Song K; Liu S; Zhang H; Wang F; Ni C; Zhai W; Liang J; Qin Z; Zhang J
    Oncoimmunology; 2020; 9(1):1725355. PubMed ID: 32117590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
    Mohs A; Kuttkat N; Otto T; Youssef SA; De Bruin A; Trautwein C
    Carcinogenesis; 2020 Apr; 41(2):171-181. PubMed ID: 30770929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
    Filliol A; Saito Y; Nair A; Dapito DH; Yu LX; Ravichandra A; Bhattacharjee S; Affo S; Fujiwara N; Su H; Sun Q; Savage TM; Wilson-Kanamori JR; Caviglia JM; Chin L; Chen D; Wang X; Caruso S; Kang JK; Amin AD; Wallace S; Dobie R; Yin D; Rodriguez-Fiallos OM; Yin C; Mehal A; Izar B; Friedman RA; Wells RG; Pajvani UB; Hoshida Y; Remotti HE; Arpaia N; Zucman-Rossi J; Karin M; Henderson NC; Tabas I; Schwabe RF
    Nature; 2022 Oct; 610(7931):356-365. PubMed ID: 36198802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological significance of myeloid differentiation factor 88 expression in human hepatocellular carcinoma tissues.
    Kinowaki K; Soejima Y; Kumagai A; Kondo F; Sano K; Fujii T; Kitagawa M; Fukusato T
    Pathol Int; 2017 May; 67(5):256-263. PubMed ID: 28370778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.